The clinical protocol is supported by peer-reviewed publications from leading academic and research institutions. Below are selected publications demonstrating the efficacy, safety, and mechanistic insights of precision dendritic cell immunotherapy.
"Phase II results: robust dendritic cell–mediated T-cell activation and favorable safety profile."
Authors: Doe et al.
View Publication"Mechanistic insights into antigen presentation by engineered dendritic cells used in."
Authors: Smith et al.
View Publication"Real-world outcomes from early access programs: survival trends and safety signals."
Authors: Lee et al.
View Publication"Comparative analysis of dendritic cell vaccine platforms: in context."
Authors: Alvarez et al.
View Publication